San Diego, CA -- (SBWire) -- 06/30/2017 --An investigation on behalf of investors in shares of Alliqua Biomedical Inc (NASDAQ:ALQA) was announced over potential breaches of fiduciary duties by certain officers and directors at Alliqua Biomedical.
Investors who purchased shares of Alliqua Biomedical Inc (NASDAQ:ALQA) certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Alliqua Biomedical officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Alliqua Biomedical Inc reported that its annual Total Revenue rose from $12.18 million 2015 to $18.24 million in 2016 and that its Net Loss increased from $27.22 million in 2015 to $32.40 million in 2016.
Shares of Alliqua Biomedical Inc (NASDAQ:ALQA) declined from $9.40 per share in early 2014 to as low as $0.32 per share on June 22, 2017
On June 29, 2017, NASDAQ:ALQA shares closed at $0.38 per share.
Those who purchased shares of Alliqua Biomedical Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Alliqua Biomedical Inc (NASDAQ:ALQA) Shareholder Notice: Investigation over Potential Wrongdoing
An investigation on behalf of investors in Alliqua Biomedical Inc (NASDAQ:ALQA) shares over potential wrongdoing at Alliqua Biomedical was announced and NASDAQ:ALQA stockholders should contact the Shareholders Foundation.